FDA Approves Qualified Health Claim for Resistant Starch, Type 2 Diabetes
Foods and beverages, including bakery, nutrition bar, and cereal and pasta products, can now use the claim.
Photo © iStockphoto.com/evgenyb
Ingredion Inc.’s (Westchester, IL) Hi-Maize high-amylose maize resistant starch has a newly approved qualified health claim from FDA linking the ingredient with a reduction in the risk of type 2 diabetes.
Foods and beverages-including bakery, nutrition bar, and cereal and pasta products-using Hi-Maize can now use the claims:
- “High-amylose maize resistant starch may reduce the risk of type 2 diabetes. FDA has concluded that there is limited scientific evidence for this claim.”
- “High-amylose maize resistant starch, a type of fiber, may reduce the risk of type 2 diabetes. FDA has concluded that there is limited scientific evidence for this claim.”
According to Ingredion, FDA based its assessment on eight clinical trials showing the positive impact of Hi-Maize on insulin sensitivity and other biomarkers related to blood sugar.
“We believe the new qualified health claim is a positive development for consumers as it provides another pragmatic approach to potential diabetes risk reduction through everyday foods,” said Lorraine Niba, PhD, global director, nutrition springboard, for Ingredion.
Also read:
Acacia Gum Granted EU Health Claim for Glycemic Reduction
Jennifer Grebow
Editor-in-Chief
Nutritional Outlook magazine
jennifer.grebow@ubm.com
U.S. Hemp Authority announces Adult Use Hemp Product Certification Program
April 15th 2024The U.S. Hemp Authority (USHA) has announced the launch of its Adult Use Hemp Product Certification Program in an effort to “reshape public policy around hemp, and to build confidence among retailers and consumers alike.”
